Cargando…

Potential metabolites of Arecaceae family for the natural anti-osteoarthritis medicine: A review

Osteoarthritis (OA) is a chronic inflammatory disorder of the joints caused by fluid and cartilage matrix component reduction. This disease results in symptoms of pain, deformity, and limitation of movement. In general, OA is treated with anti-inflammatory drugs and chondroprotection compounds, incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sartinah, Ari, Nugrahani, Ilma, Ibrahim, Slamet, Anggadiredja, Kusnandar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763769/
https://www.ncbi.nlm.nih.gov/pubmed/36561673
http://dx.doi.org/10.1016/j.heliyon.2022.e12039
_version_ 1784853133440057344
author Sartinah, Ari
Nugrahani, Ilma
Ibrahim, Slamet
Anggadiredja, Kusnandar
author_facet Sartinah, Ari
Nugrahani, Ilma
Ibrahim, Slamet
Anggadiredja, Kusnandar
author_sort Sartinah, Ari
collection PubMed
description Osteoarthritis (OA) is a chronic inflammatory disorder of the joints caused by fluid and cartilage matrix component reduction. This disease results in symptoms of pain, deformity, and limitation of movement. In general, OA is treated with anti-inflammatory drugs and chondroprotection compounds, includes natural nutraceutical ingredients, which are expected to be effective and have minimal side effects. Arecaceae plants are widely spread worldwide, especially in tropical areas. The objective of this review is to collect information about the Arecaceae family as anti-OA agents, with the main study focusing on the primary and secondary metabolites of plants of the Arecaceae family, i.e., sugar palm (Arenga pinnata), nipa palm (Nypa fruticans), palmyra palm (Borassus flabellifer), date palm (Phoenix dactylifera), and betel nut (Areca catechu) have potential as anti-OA agents. The Arecaceae's metabolites that show anti-inflammatory and chondroprotective effects are galactomannan, fatty acids (linoleic and linolenic acids), flavonoids (quercetin, luteolin, isorhamnetin), phenolics (coumaric acid, ferulic acid), polyphenols (epicatechin), and steroids (stigmasterol, campesterol, spirostane). Based on the reports, the Arecaceae family plants become worthy of being explored and developed into natural anti-OA products, such as supplements or nutraceuticals.
format Online
Article
Text
id pubmed-9763769
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-97637692022-12-21 Potential metabolites of Arecaceae family for the natural anti-osteoarthritis medicine: A review Sartinah, Ari Nugrahani, Ilma Ibrahim, Slamet Anggadiredja, Kusnandar Heliyon Review Article Osteoarthritis (OA) is a chronic inflammatory disorder of the joints caused by fluid and cartilage matrix component reduction. This disease results in symptoms of pain, deformity, and limitation of movement. In general, OA is treated with anti-inflammatory drugs and chondroprotection compounds, includes natural nutraceutical ingredients, which are expected to be effective and have minimal side effects. Arecaceae plants are widely spread worldwide, especially in tropical areas. The objective of this review is to collect information about the Arecaceae family as anti-OA agents, with the main study focusing on the primary and secondary metabolites of plants of the Arecaceae family, i.e., sugar palm (Arenga pinnata), nipa palm (Nypa fruticans), palmyra palm (Borassus flabellifer), date palm (Phoenix dactylifera), and betel nut (Areca catechu) have potential as anti-OA agents. The Arecaceae's metabolites that show anti-inflammatory and chondroprotective effects are galactomannan, fatty acids (linoleic and linolenic acids), flavonoids (quercetin, luteolin, isorhamnetin), phenolics (coumaric acid, ferulic acid), polyphenols (epicatechin), and steroids (stigmasterol, campesterol, spirostane). Based on the reports, the Arecaceae family plants become worthy of being explored and developed into natural anti-OA products, such as supplements or nutraceuticals. Elsevier 2022-12-06 /pmc/articles/PMC9763769/ /pubmed/36561673 http://dx.doi.org/10.1016/j.heliyon.2022.e12039 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Article
Sartinah, Ari
Nugrahani, Ilma
Ibrahim, Slamet
Anggadiredja, Kusnandar
Potential metabolites of Arecaceae family for the natural anti-osteoarthritis medicine: A review
title Potential metabolites of Arecaceae family for the natural anti-osteoarthritis medicine: A review
title_full Potential metabolites of Arecaceae family for the natural anti-osteoarthritis medicine: A review
title_fullStr Potential metabolites of Arecaceae family for the natural anti-osteoarthritis medicine: A review
title_full_unstemmed Potential metabolites of Arecaceae family for the natural anti-osteoarthritis medicine: A review
title_short Potential metabolites of Arecaceae family for the natural anti-osteoarthritis medicine: A review
title_sort potential metabolites of arecaceae family for the natural anti-osteoarthritis medicine: a review
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763769/
https://www.ncbi.nlm.nih.gov/pubmed/36561673
http://dx.doi.org/10.1016/j.heliyon.2022.e12039
work_keys_str_mv AT sartinahari potentialmetabolitesofarecaceaefamilyforthenaturalantiosteoarthritismedicineareview
AT nugrahaniilma potentialmetabolitesofarecaceaefamilyforthenaturalantiosteoarthritismedicineareview
AT ibrahimslamet potentialmetabolitesofarecaceaefamilyforthenaturalantiosteoarthritismedicineareview
AT anggadiredjakusnandar potentialmetabolitesofarecaceaefamilyforthenaturalantiosteoarthritismedicineareview